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https://doi.org/10.1002/aoc.4658The reaction of α‐keto‐stabilized diphosphine ylides [Ph2P(CH2)nPPh2═C(H)
C(O)C6H4‐p‐CN] (n = 1 (Y
1); n = 2 (Y2)) with dibromo(1,5‐cyclooctadiene)
palladium(II)/platinum(II) complexes, [Pd/PtBr2(cod)], in equimolar ratio
gave the new cyclometalated Pd(II) and Pt(II) complexes [Br2Pd(κ
2
‐Y1)]
(1), [Br2Pt(κ
2
‐Y1)] (2), [Br2Pd(κ
2
‐Y2)] (3) and [Br2Pt(κ
2
‐Y2)] (4). These com-
pounds were screened in a search for novel antibacterial agents and charac-
terized successfully using Fourier transfer infrared and NMR (1H, 13C and
31P) spectroscopic methods. Also, the structures of complexes 1 and 2 were
characterized using X‐ray crystallography. The results showed that the P,C‐
chelated complexes 1 and 2 have structures consisting of five‐membered
rings, while 3 and 4 have six‐membered rings, formed by coordination of
the ligand through the phosphine group and the ylidic carbon atom to
the metal centre. Also, a theoretical study of the structures of complexes
1–4 was conducted at the BP86/def2‐SVP level of theory. The nature of
metal–ligand bonds in the complexes was investigated using energy decom-
position analyses (EDA) and extended transition state combined with natu-
ral orbitals for chemical valence analyses. The results of EDA confirmed
that the main portions of ΔEint, about 57–58%, in the complexes are allo-
cated to ΔEelstat.
KEYWORDS
antibacterial activity, DFT, EDA, Pd/Pt complexes, X‐ray1 | INTRODUCTION
Unsymmetric α‐keto‐stabilized ylides derived from
diphosphines have shown useful applications in organo-
metallic and inorganic chemistry,[1–6] especially in the
synthesis of products with biological and pharmacological
activities.[7–9] The development of compounds with the
ability to inhibit bacterial growth has been of greatwileyonlinelibrary.cominterest in recent years.[10] Even though pharmacological
industries have produced a number of new antibiotics in
the last three decades, resistance to these drugs by micro-
organisms has increased. The problem of microbial
resistance is growing and the outlook for the use of anti-
microbial drugs in the future is still uncertain. Therefore,
actions must be taken to mitigate this problem, for exam-
ple to control the use of antibiotics, develop research to© 2018 John Wiley & Sons, Ltd./journal/aoc 1 of 13
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and to continue studies to develop new drugs, either syn-
thetic or natural. The utility of metalated phosphorus
ylides in synthetic chemistry has been well docu-
mented.[11,12] The coordination and organometallic chem-
istry of α‐keto‐stabilized phosphorus ylides has been
investigated extensively and their ambidenticity explained
in terms of a delicate balance between electronic and ste-
ric factors.[13–18] Juxtaposition of the keto group and carb-
anion in the phosphorus ylides causes delocalization of
the ylidic electron density, and it provides additional sta-
bility in the ylide species.[19–22] Also, the basicity or steric
properties of the two phosphorus atoms can be different
and may be used to get different coordination modes, i.e.
bidendate versus monodendate.[23] Because of various
coordination modes of α‐keto‐stabilized phosphorus
ylides in metal complexes (P‐, C‐ and P,C‐coordination
modes), these compounds are attractive candidates for
further development in Pd‐/Pt‐based complexes.[24,25]
Experimental and theoretical studies of the reactivity
and coordination chemistry of carbonyl‐stabilized phos-
phorus ylides are an important research field of our
group.[9] Complexes of group 10 metals (especially
palladium(II) and platinum(II)) with phosphorus ylide
ligands have attracted the interest of researchers as objects
for theoretical studies. Although there is no X‐ray struc-
ture available in this report to prove the molecular struc-
tures of complexes 3 and 4, density functional theoretical
studies using natural bond order, energy decomposition
analysis (EDA) and extended transition state combined
with natural orbitals for chemical valence (ETS‐NOCV)
analysis have been performed to elucidate the physical
and chemical nature of interactions and this is one of
the purposes of the reported work.
Because of the similar coordination modes and
chemical properties of Pd(II) and Pt(II) complexes, also
the structural analogy between Pt(II) and Pd(II) com-
plexes, we were encouraged to conduct synthetic, struc-
tural characterization, crystallographic and theoretical
studies of these complexes with some unsymmetric α‐
keto‐stabilized phosphorus ylides. These ylides have
been coordinated to various transition metal ions such
as Hg(II), Ag(I), Cu(I) as well as Pd(II) and Pt(II).[26,27]
In the work reported here, we selected the ylides
[Ph2P(CH2)nPPh2═C(H)C(O)C6H4‐p‐CN] (n = 1 (Y
1);
n = 2, (Y2)) to participate as ligands for the prepara-
tions of some cyclometal complexes. As a part of our
interest in transition metal chemistry of bidentate
phosphorus‐based ylides for cyclometalation, we con-
centrated on the preparation and geometric and elec-
tronic properties of new four‐coordinated Pd(II)/Pt(II)
complexes with the idea of studying the nature of
metal–ligand bonds.2 | EXPERIMENTAL
2.1 | Materials and methods
All synthetic reactions were carried out under dry nitro-
gen using standard Schlenk techniques. 2‐Bromo‐4′‐
cyanoacetophenone, dppe and dppm were purchased
from commercial sources and used without further purifi-
cation. [MBr2(cod)] (M = Pd or Pt) complexes were pre-
pared according to previously published procedures.[28]
Phosphorus ylides Y1 and Y2 were synthesized and char-
acterized previously.[29] Toluene, n‐hexane and chloro-
form were used as reagent grade and dried over
Na/benzophenone and CaCl2 successively.
1H NMR, 13C
NMR and 31P NMR spectra were recorded with
250 MHz Bruker and 90 MHz Jeol spectrometers with
CDCl3 as solvent at 25°C. Infrared (IR) spectra were
recorded with KBr pellets using a Shimadzu 435‐U04
spectrophotometer in the region 400–4000 cm−1.2.2 | Synthesis of Pd/Pt complexes
In a general procedure, to a dichloromethane solution of
[MBr2(cod)] (0.5 mmol, 5 ml), a solution of ylide
(0.5 mmol) (5 ml, CH2Cl2) was added. The resulting
solution was stirred for 2 h at room temperature and then
concentrated to a ca 2 ml under reduced pressure and
treated with n‐hexane (5 ml) to afford the Pd/Pt
complexes of desired diphosphine ylide.2.2.1 | Data for [PdBr2(Ph2PCH2PPh2C(H)
C(O)C6H4‐p‐CN)] (1)
Yield: 0.061 g (88%); m.p. 205°C. Selected IR (KBr, cm−1):
1682 (C═O). 1H NMR (250.13 MHz, CDCl3, δH, ppm):
4.22 (s, CH2, 2H), 6.31 (br, 1H, PCH), 6.31–8.47 (m, 20H
Ph + 4H C6H4).
31P NMR (101.24 MHz, CDCl3, δP,
ppm): 26.05 (d, PPh2,
2JP–P = 45.45 Hz), 37.97 (d, PCH,
2JP–P = 45.45 Hz).
13C NMR (62.89 MHz, CDCl3, δC,
ppm): 28 (s, CH2), 38.70 (s, PCH), 118.24 (s, CN),
121.34–140.32 (m, Ph), 194.79(s, CO).2.2.2 | Data for [PtBr2(Ph2PCH2PPh2C(H)
C(O)C6H4‐p‐CN)] (2)
Yield: 0.050 g (80%); m.p. 200°C. IR (KBr, cm−1): 1685
(C═O). 1H NMR (250.13 MHz, CDCl3, δH, ppm): 4.28
(br, 2H, CH2), 4.91 (t, H, PCH), 6.94–7.85 (m, 20H Ph + 4H
C6H4).
31P NMR (101.24 MHz, CDCl3, δP, ppm): 5.78 (td,
PPh2,
1JPt–P = 1928.09 Hz), 42.95 (d, PCH,
2JP–
P = 41.41 Hz).
13C NMR (62.89 MHz, CDCl3, δC, ppm):
SABOUNCHEI ET AL. 3 of 1338.70 (s, CH2), 46.22 (m, PCH), 118.07 (s, CN), 127.60–
134.21 (m, Ph), 192 (s, CO).2.2.3 | Data for
[PdBr2(Ph2PCH2CH2PPh2C(H)C(O)C6H4‐p‐
CN)] (3)
Yield: 0.051 g (85%); m.p. 201°C. Selected IR (KBr, cm−1):
1626 (C═O). 1H NMR (250.13 MHz, CDCl3, δH, ppm):
4.22 (br, 4H, CH2), 6.31 (s, 1H, PCH), 7.16–8.47 (m, 20H
Ph + 4H C6H4).
31P NMR (101.24 MHz, CDCl3, δP,
ppm): 23.59 (d, PPh2,
2JP–P = 23.23 Hz), 28.17 (d, PCH,
2JP–P = 22.22 Hz).
13C NMR (62.89 MHz, CDCl3, δC,
ppm): 22.96 (s, CH2), 30.33 (s, PCH), 118.24 (s, CN),
121.34–140 (m, Ph), 194.61 (s, CO).2.2.4 | Data for
[PtBr2(Ph2PCH2CH2PPh2C(H)C(O)C6H4‐p‐
CN)] (4)
Yield: 0.060 g (95%); m.p. 200–205°C. IR (KBr, cm−1):
1628 (C═O). 1H NMR (250.13 MHz, CDCl3, δH, ppm):
3.7 (m, 4H, CH2), 6.47 (br, 1H, PCH), 7.125–8.66 (m,
20H Ph + 4H C6H4).
31P NMR (101.24 MHz, CDCl3, δP,
ppm): 6.48 (td, PPh2,
1JPt–P = 3910.89 Hz), 20.14 (td,
PCH, 2JP–P = 153.5 Hz).
13C NMR (62.89 MHz, CDCl3,
δC, ppm): 38.90 (s, CH2), 45.66 (s, PCH), 118.24 (s, CN),
127.20–140.86 (m, Ph), 194.50 (s, CO).2.3 | Crystallography
Single crystals of 1 and 2were crystallized by slow evapora-
tion from dichloromethane solution. A suitable crystal was
selected and mounted on a SuperNova, Dual, Cu at zero,SCHEME 1 Synthesis of Y1, Y2and Pt/Pd complexes 1–4Atlas diffractometer. The crystal was kept at 130.00(10) K
during data collection. Using Olex2,[30] the structure was
solved with the ShelXT[31] structure solution program
using intrinsic phasing and refined with the ShelXL[32]
refinement package using least squares minimization.2.4 | Computational studies
A computational study was conducted of structures and
nature of metal–ligand bonds in some complexes of five‐
and six‐membered ring, P,C‐chelated complexes of Pd(II)
and Pt(II) with general formula [YMBr2] (M = Pd, Pt;
Y = Y1, Y2). The geometries of the complexes were opti-
mized at BP86/def2‐SVP level of theory.[33–35] Vibrational
frequency analyses, calculated at the same level of theory,
indicate that the optimized structures are at the stationary
points corresponding to local minima without any imagi-
nary frequency. All calculations were performed using the
Gaussian 09 set of programs.[36] It has been shown in for-
mer studies that BP86 is a suitable level for calculation of
the bonding situation of M ← L in such as these com-
plexes.[37–52] For bonding analyses, the terms of EDA were
carried out at BP86/TZ2P(ZORA)//BP86/def2‐SVPwithC1
symmetry. The basis sets for all elements have triple‐ζ
quality augmented by one set of polarization functions
(ADF basis set TZ2P (ZORA)) with the program package
ADF2009.01.2.5 | Antibacterial activity
The antimicrobial effect of the new complexes was
assessed using the disc diffusion method.[53] Paper discs
(6.4 mm in diameter) were submerged in sample solutions.
The samples were dissolved in dimethylsulfoxide (DMSO)
to make a 1 mg ml−1 solution and other concentrations
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blank sterile paper discs. Dried discs were placed onto
Muller‐Hinton agar medium previously inoculated with a
bacterial suspension (1.5 × 108 bacteria ml−1). The cultures
were incubated at 37°C for 24 h. Antibacterial activities of
the new complexes were evaluated against two Gram‐
positive bacteria, namely Staphylococcus aureus (ATCC
25923) and Bacillus subtilis (PTCC 1247), and two Gram‐
negative bacteria, namely Escherichia coli (ATCC 35218)
and Pseudomonas aeruginosa (ATCC 27853), at two differ-
ent concentrations (1 and 0.5 mg ml−1). The antibacterial
activity against each test organismwas quantified by deter-
mining the mean zone of inhibition. Negative controls
were prepared using DMSO. Gentamicin, penicillin and
streptomycin were used as positive reference standards.TABLE 1 Spectroscopic data for compounds Y1, Y2 and 1–4
Compound IR; ν(CO) (cm−1) 1H NMR; δ (PCH) (ppm) 13C
Y1 1572 4.33 183
1 1682 6.31 194
2 1685 4.91 192
Y2 1570 4.26 188
3 1626 6.31 194
4 1628 6.47 194
FIGURE 1 31P NMR spectra of complexes 1 and 22.6 | Statistical analyses
All data from antibacterial experiments are the average of
triplicate analyses. Analysis of variance was performed
using Excel and SPSS procedures. Statistical analysis
was performed using Duncan's test and a value of
p < 0.05 was regarded as significant.3 | RESULTS AND DISCUSSION
3.1 | Synthesis
Reaction of ligands Y1 and Y2 with [MBr2(cod)] in equi-
molar ratio yielded the new P,C‐chelated palladacyclesNMR; δ (CO) (ppm) 31P NMR; δ (PCH) and (PPh2) (ppm)
.18 15.35, −29.48
.79 37.97, 26.05
42.95, 5.78
.79 17.18, −12.83
.61 28.17, 23.59
.50 20.14, 6.48
FIGURE 2 ORTEP views of X‐ray
crystal structures of 1 and 2
SABOUNCHEI ET AL. 5 of 13and platinacycles 1–4 in 80–95% yields (Scheme 1). All
complexes are soluble in chloroform and dichlorometh-
ane and insoluble in non‐polar solvents such as n‐hexane
and petroleum ether.3.2 | Characterization
The structures of products were characterized success-
fully using 1H NMR, 13C NMR and 31P NMR spectro-
scopic methods and other techniques as well as IR
spectroscopy and X‐ray crystallography. Table 1 presents
a brief summary of these collected datasets. Also, the
exact structures of complexes 1 and 2 with atomic
resolution were unequivocally determined using the
single‐crystal X‐ray diffraction technique.3.2.1 | IR spectra
As noted in the literature,[54] coordination of ylide
through carbon (chelating mode) causes a significantTABLE 2 Crystal data and structure refinement for 1 and 2
1
Empirical formula C34H27Br2NOP2Pd
Formula weight 793.71
T (K) 100.0(1)
Crystal system Monoclinic
Space group C2/c
a (Å) 22.9998(5)
b (Å) 15.4956(3)
c (Å) 18.4400(3)
α (°) 90
β (°) 108.290(2)
γ (°) 90
V (Å3) 6239.9(2)
Z 8
Dc (Mg m
−3) 1.690
μ (mm−1) 3.287
F (000) 3136.0
λ (Mo Kα) 0.71073
2θ range (°) 4.968 to 59.324
Index ranges −27 ≤ h ≤ 31, −21 ≤ k ≤ 18, −25
Reflections collected 35 911
Independent reflections 7773 [Rint = 0.0635, Rsigma = 0.05
Data/restr./param. 7773/0/370
Goodness‐of‐fit on F 2 1.047
R1/wR2[I > 2σ(I)] R1 = 0.0387, wR2 = 0.0744increase in the ν(CO) frequency. IR spectra of complexes
1–4 show a significant frequency shift of ν(CO) compared
to those of the related phosphorus ylides Y1 and Y2. These
observations are in agreement with the chelation of ylides
through the P and Cα atoms. The presence of ν(CO)
bands at around 1600 cm−1 in the IR spectra of these
complexes indicates that products (P,C‐chelated com-
plexes) were formed. Furthermore, the IR spectra of com-
plexes 1–4 did not show the ν(CO) bands at around
1500 cm−1, confirming that there are no significant
amounts of P,P‐coordinated complexes as side products.3.2.2 | NMR spectral data
Coordination of phosphorus ylides as P,C‐chelated form
can lead to a large chemical shift for both free (PPh2) and
bonded (PCH) phosphorus atoms. While, in P,P‐ coordi-
nated form it is only the signal of PPh2 moiety that is
shifted to higher frequencies. The 31P NMR chemical shift
values for all complexes appear to be shifted downfield2
C34H27Br2NOP2Pt
882.41
130.00(10)
Monoclinic
C2/c
23.0102(3)
15.52552(20)
18.4538(2)
90
108.0847(14)
90
6266.85(15)
8
1.871
12.550
3392.0
0.71073
6.982 to 154.132
≤ l ≤ 24 −28 ≤ h ≤ 29, −19 ≤ k ≤ 18, −18 ≤ l ≤ 23
18 489
98] 6592 [Rint = 0.0311, Rsigma = 0.0272]
6592/0/370
1.106
R1 = 0.0259, wR2 = 0.0660
TABLE 3 Selected bond lengths (Å) and bond angles (°) for 1
and 2
1 2
Bond distances
Pd1–Br1 2.4577(4) Pt1–Br1 2.4625(3)
Pd1–Br2 2.4973(4) Pt1–Br2 2.4912(3)
Pd1–P2 2.2262(8) Pt1–P1 2.2055(7)
Pd1–C1 2.105(3) Pt1–C1 2.086(3)
O1–C2 1.233(4) O1–C2 1.224(4)
C1–C2 1.490(4) C1–C2 1.506(4)
P1–C1 1.782(3) P2–C1 1.792(3)
P1–C10 1.802(3) P1–C22 1.853(3)
Bond angles
Br2–Pd1–Br1 92.594(13) Br2–Pt1–Br1 91.022(12)
C1–Pd1–P2 89.14(9) C1–Pt1–P1 89.92(8)
C1–Pd1–Br1 172.53(8) C1–Pt1–Br2 91.47(8)
P2–Pd1–Br1 86.91(2) P1–Pt1–Br1 88.35(2)
P2–Pd1–Br2 170.29(2) P1–Pt1–Br2 171.054(19)
6 of 13 SABOUNCHEI ET AL.with respect to all parent ylides, indicating that coordina-
tion of the ylides has occurred. The 31P NMR spectrum of
complex 1 shows two doublet peaks at around 26.05 and
37.97 ppm, which are assigned to PPh2 (Pa) and PCH
(Pb), respectively (Figure 1), whereas the
31P NMR spec-
trum of complex 2 shows two doublet peaks at around
5.78 ppm along with two satellite peaks due to 195Pt–31P
coupling at 42.95 ppm, which are assigned to PPh2 (Pa)
and PCH (Pb), respectively (Figure 1). The
31P NMR spec-
trum of complex 3 shows two doublet peaks at around
23.59 and 28.17 ppm, which are assigned to PPh2 and
PCH, respectively (Figure S9, supporting information).
The 31P NMR spectrum of complex 4 shows a different pat-
tern with two doublet peaks at around 6.48 and 20.14 ppm,
along with two satellite peaks due to 195Pt–31P coupling,
which are assigned to PPh2 and PCH, respectively (Figure
S13, supporting information).
The 1H NMR chemical shift values for these com-
plexes appear to be shifted downfield with respect to the
parent ylide, indicating also that coordination of the ylide
through P and Cα atoms has occurred. The 1H NMR spec-
tra of P,C‐chelated complexes 1–4 (Figures S2, S6, S10
and S14, supporting information) exhibited characteristic
shifts in the methinic proton signals. This is interesting,
because complexation of the ylides (Y1/Y2) to Pd/Pt
through free phosphorus atom does not change signifi-
cantly the chemical shift values of 1H NMR. While, coor-
dination through carbanion causes a shift of PCH peaks
to higher frequency at around 4.91–6.47 ppm. The 1H
NMR spectra of complexes 1–4 show the signal of the
methinic proton as a broad peak at around 6 ppm due
to the coupling with the neighbour phosphorus atoms.
The 13C NMR spectra of complexes 1 and 2 (Figures
S3 and S7, supporting information) showed downfield
shift of CO, PCH and PCH2 groups in respect to the par-
ent ylide Y1. Chemical shift values in the 13C NMR spec-
tra of complexes 3 and 4 (Figures S11 andS15, supporting
information) showed significant shift in comparison to
the parent ylide Y2. This observation also confirmed that
coordination of ylides Y1 and Y2 occurred through the P,
C‐coordination sites.3.3 | Crystallography
Single crystals of 1 and 2 were obtained by slow evapora-
tion from dichloromethane. The molecular structures of 1
and 2 are shown in Figure 2. Relevant parameters
concerning data collection and refinement are given in
Table 2. Selected bond distances and angles for the unit
cells of 1 and 2 are presented in Table 3. (See supporting
information, Tables S1–S15.)The structures of 1 and 2 are as proposed. The Pt/Pd
centres are in a slightly distorted square planar environ-
ment, coordinated by two bromine atoms one phosphorous
atom and one ylidic carbon atom. The four coordinating
atoms show a slight tetrahedral distortion with a root‐
mean‐square deviation of 0.139 Å. The five‐membered ring
formed by the coordination of the ligand to the platinum is
in an envelope conformation, with C1 lying 0.820(3) Å out
of the plane of the other four atoms: Pt1, P2, P3 and C22.
The Pt─Br distance trans to the ylidic carbon
atom, 2.4625(3) Å, is slightly shorter than the correspond-
ing distance trans to the phosphorus atom, 2.4912(3) Å.
The dihedral angle between the keto group and the
cyano‐substituted aromatic ring is 16.1(2)°. The
structure is similar to that of other Pd ylide complexes, such
as dichloro‐(1‐(((diphenylphosphino)methyl)(diphenyl)
phosphonio)‐2‐(2‐naphthyl)‐2‐oxoethyl)palladium(II)[55]
and (2‐(biphenyl‐4‐yl)‐1‐(((diphenylphosphino)methyl)
(diphenyl)phosphonio)‐2‐oxoethyl)(dichloro)palladium.[29]
Crystal data for C34H27Br2NOP2Pd
(M = 793.71 g mol−1): monoclinic, space group C2/c
(no. 15), a = 22.9998(5) Å, b = 15.4956(3) Å,
c = 18.4400(3) Å, β = 108.290(2)°, V = 6239.9(2) Å3,
Z = 8, T = 100.0(1) K, μ(Mo Kα) = 3.287 mm−1.3.4 | Theoretical studies
A computational study of structures and nature of metal–
ligand (M → L) bonds in [YMBr2] (M = Pd, Pt; Y = Y
1,
SABOUNCHEI ET AL. 7 of 13Y2) complexes was conducted at the BP86 level of theory
using the def2‐SVP basis set. The structural data obtained
(Figure 4) show that the Y1 complexes of Pd and Pt are
monomeric P,C‐chelate complexes with five‐membered
rings which lie in a square planar geometry around the
metal centre. Also, this work and previous experimental
data[39] confirm that, upon complexation of the Y1 and
Y2 ligands, the monomeric P,C‐chelate complexes are
formed as five‐ and six‐membered rings with a square
planar geometry around the metal centre.
The optimized structures of the [YMBr2] complexes
at BP86/Def2‐SVP are shown in Figure 3 and the trends
for the variation of the corresponding bond lengths and
bond angles and their comparison with experimental
data are presented in Table 4. (See supporting informa-
tion, Tables S16–S19.) The results are good agreement
with experiment and also our recent work,[40] showing
that changing the ligand from Y1 to Y2 and M from Pd
to Pt has an insignificant effect on the values of
C → M and P → M bond lengths. Also, the calculated
and experimental C → M and P → M bond lengths in
the complexes are in ranges 2.09–2.14 and 2.20–2.29 Å,
respectively. On the other hand, the P─M─C bond angle
in six‐membered ring complexes is greater than that in
five‐membered ring complexes (see Figure 3 and
Table 4).FIGURE 3 Optimized structures of
[YMBr2] (M = Pd, Pt; Y = Y
1, Y2)
complexes at the BP86/SVP level of
theory. Bond lengths are given in
angstroms, bond angles in degreesMorokuma[56] and Ziegler and Rauk[57] developed
EDA in the 1970s. Using this technique, a quantitative
computational pattern is in hand for the explanation of
the strength of M ← L σ donation, and M → L back‐
bonding in main group and transition metal complexes
with different types of ligands.[37–52,58–62]
In continuation, through EDA, the strength and
nature of donor–acceptor bonds between the phosphorus
ylides (Y1, Y2) and MBr2 fragment were investigated at
BP86/TZ2P(ZORA)//BP86/def2‐SVP with C1 symmetry
using the program package ADF2009.01. The results of
EDA for all of the complexes are presented in Table 5.
In EDA, the bonding formation of interacting fragments
would result from four main components as follows:
ΔEint ¼ ΔEelstat þ ΔEPauli þ ΔEorb þ ΔEdisp
where ΔEelstat is electrostatic interaction, ΔEPauli is
Pauli repulsion, ΔEorb is orbital interaction and ΔEdisp is
dispersion energy between two fragments. The results of
EDA confirm that the main portions of ΔEint, about 57–
58%, in the complexes are allocated to ΔEelstat (see
Table 5).
Also, the visualizations of NOCV pairs (Δρ) between
the donor orbitals of phosphorus ylides (Y1, Y2) and the
acceptor orbitals of the MBr2 fragment are shown in
FIGURE 4 Deformation densities associated with the most important orbital interactions for [YPdBr2] complexes
TABLE 4 Selected bond lengths (Å) and bond angles (°) of [YMBr2] (M = Pd, Pt; Y = Y
1, Y2) complexes at the BP86/def2‐SVP level of
theory (the values given in parentheses are those corresponding to the experimental data)
Bond lengths [Y1PdBr2] [Y
2PdBr2] [Y
1PtBr2] [Y
2PtBr2]
M–C (ylide) 2.14 (2.10) 2.15 2.13 (2.09) 2.14
M–P 2.27 (2.23) 2.29 2.25 (2.20) 2.26
M–Br 2.49 (2.50) 2.49 2.51 (2.49) 2.51
Bond angles
P–M–C 90.77 (89.2) 96.49 90.75 (89.92) 96.81
Br–M–Br 92.78 (92.59) 88.92 90.99 (91.02) 88.78
P–M–Br 87.71 (86.94) 87.05 90.15 (88.35) 88.94
C–M–Br 89.47 (92.35) 87.65 88.57 (91.48) 88.62
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TABLE 5 EDA (BP86/SVP (ZORA)//BP86/def2‐SVP) of [YMBr2] (M = Pd, Pt; Y = Y
1, Y2) complexes with C1 symmetry
Parameter [Y1PdBr2] [Y
1PtBr2] [Y
2PdBr2] [Y
2PtBr2]
ΔEint −116.36 −150.29 −120.03 −151.52
ΔEPauli 267.36 344.69 258.48 332.92
ΔEelast −222.50(57.9) −287.57(58.1) −216.16 −277.51(57.3)
ΔEorb −141.02(36.7) −181.98(36.7) −141.19 −180.39(37.2)
ΔEdis −20.20(5.4) −25.44(5.2) −21.16 −26.54(5.5)
ΔEorb, σd −72.57(61.3) −83.72(54.3) −71.92 −82.18(54.4)
ΔEorb, σd −18.55(15.7) −36.50(23.7) −20.05 −37.99(25.2)
ΔEorb, π┴ −11.76(9.9) −14.52(9.4) −9.28 −12.12(8.1)
ΔEorb, π‖ −8.51(7.3) −12.30(8.0) −9.36 −12.97(8.6)
ΔEorb, π┴ −6.91(5.8) −7.16(4.6) −5.67 −5.65(3.7)
ΔEorb, rest −10.89 −12.74 −9.57 −12.63
SABOUNCHEI ET AL. 9 of 13Figures 4 and 5. As can be seen, the dominant term of
ΔEorb for all of the complexes arises from σ‐orbital
interactions (Δρ1, Δρ2). The calculated data show that
the σ‐orbital interactions account for 77–80% of the
ΔEorb term for the studied complexes. Also, the shapes
of the orbital pairs of Δρ3, Δρ4 and Δρ5 refer to π
back‐donations which are in plane and out of plane and
account for about 20–23% of the ΔEorb term (see Table 5
and Figures 4 and 5).3.5 | Antibacterial activity
Antibacterial activities of the complexes were evaluated
against E. coli, P. aeruginosa, S. aureus and B. cereus using
the disc diffusion method at two different concentrations.
It is well known that S. aureus, E. coli and Bacillus species
are food poisoning agents.[63,64] The solvent DMSO,
which was screened as a negative control against all bac-
teria, had no activity. Results from the antibacterial
assessment are presented in Tables 6 and 7. Antibacterial
properties of the samples showed acceptable concentra-
tion dependence in comparison with positive controls. It
has been shown that the biological activity of a com-
pound is mainly attributed to its major components, and
also the synergistic or antagonistic effect of its compo-
nents in a minor percentage of the reaction mixture.[65]
Antibacterial activities of the samples especially the Pd
complexes compared to the reference antibiotics were
found to be good. The presence of Pd groups leads to a
number of changes in antibacterial activity between the
tested complexes (Table 6). Complexes 3 and 4, which
are modified structures of 1, showed high antibacterial
activity. The results revealed that the complexes exhibit
antibacterial activities similar to and even higher thanthose of similar Pd(II)/Pt(II) complexes.[9,66,67] On the
whole, based on the results of antibacterial experiments
and comparative study, it can be concluded that the metal
ions have an important effect on antibacterial activity and
also primary ligands can exert additional effects on the
antibacterial activity.
In addition, S. aureus was the most sensitive bacte-
rium to the complexes at both concentrations, while E.
coli was the most insensitive bacterium. The antibacterial
activity was more pronounced for the Gram‐positive bac-
teria (S. aureus and B. cereus) than the Gram‐negative
ones (E. coli and P. aeruginosa). The reason for the differ-
ence in sensitivity between them might be ascribed to the
differences in morphology between these microorgan-
isms. The Gram‐negative bacteria have an outer
phospholipidic membrane carrying the structural lipo-
polysaccharide components. This makes the cell wall
impermeable to antimicrobial chemical substances. The
Gram‐positive bacteria on the other hand are more sus-
ceptible, having only an outer peptidoglycan layer, which
is not an effective permeability barrier. Therefore, the cell
walls of Gram‐negative organisms act as a diffusion bar-
rier and making them less susceptible to antimicrobial
agents than Gram‐positive bacteria.[68,69] In spite of these
permeability differences, however, some of the samples
still exerted some degree of inhibition against Gram‐
negative organisms as well.
Therefore, our results revealed that the newly synthe-
sized complexes have great potential as antimicrobial
compounds against microorganisms. Thus, they may be
used in the treatment of infectious diseases caused by
resistant microbes. The synergistic effect of the associa-
tion of antibiotics with the complexes against resistant
bacteria leads to new choices for treatment of infectious
diseases.
FIGURE 5 Deformation densities associated with the most important orbital interactions for [YPtBr2] complexes
TABLE 6 Average inhibition zone of evaluated bacteria against the newly synthesized complexes
Sample Concentration (mg ml−1) S. aureus (+) B. cereus (+) E. coli (−) P. aeruginosa (−)
1 0.5 12.33a ± 0.57 NA 10.67b ± 0.57 NA
1 12.67a ± 1.15 NA 13.33a ± 1.52 NA
2 0.5 NA NA NA 11.64a ± 0.57
1 NA 11b ± 1 NA 14.67a ± 0.57
3 0.5 19.6a ± 0.35 14.67b ± 0.5 7.33c ± 0.57 14.33b ± 0.5
1 19.67a ± 0.57 17.67b ± 0.5 7.67d ± 0.54 14.6c ± 0.57
4 0.5 NA 9.33a ± 0.58 8.7a ± 0.42 NA
1 12.61a ± 0.58 10.67b ± 0.57 9.1b ± 0.51 NA
Experiment was performed in triplicate and expressed as mean ± SD. Values in each column with different superscripts are significantly different (p < 0.05).
NA, not active.
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TABLE 7 Antibacterial activity of antibiotics (positive controls) and DMSO (negative control)
Microorganism
Inhibition zone (mm)
Positive control Negative control
Gentamicin Penicillin Nitrofurantoin Neomycin DMSO
S.aureus (+) 35 ± 0.24 Na 30 ± 0.34 25 ± 0.45 NA
B. cereus (+) 25 ± 0.18 Na 10 ± 0.12 20 ± 0.36 NA
E. coli (−) Na Na 25 ± 0.22 20 ± 0.33 NA
P.aeruginosa (−) 33 ± 0.34 NA 11 ± 0.12 17 ± 0.12 NA
Experiment was performed in triplicate and expressed as mean ± SD. Values in each column with different superscripts are significantly different (p < 0.05).
NA, not active.
SABOUNCHEI ET AL. 11 of 134 | CONCLUSIONS
The present study describes the synthesis and characteri-
zation of a series of chelate Pd(II)/Pt(II) complexes
derived from [Pd/PtBr2cod] and bifunctionalized phos-
phorus ylides (Y1and Y2). The synthesis involved simple
and convenient methods with products obtained in satis-
factory yields. On the basis of the physicochemical and
spectroscopic data, we propose that the ligands exhibit
bidendate P,C‐coordination to the metal centre, which is
further confirmed by the X‐ray crystal structure of com-
plexes 1 and 2. The nature of metal–ligand bonds in the
complexes was investigated using EDA and ETS‐NOCV.
The results of EDA confirm that the main portions of
ΔEint, about 57–58%, in the complexes are allocated to
ΔEelstat. Also, the ETS‐NOCV analyses confirm that the
NOCV pairs (Δρ) between the donor orbitals of phospho-
rus ylides (Y1, Y2) and the acceptor orbitals of MBr2 frag-
ments arise from σ‐orbital interactions (about 77–80%)
and π back‐donation (about 20–23%) to the ΔEorb term.
Furthermore these compounds exhibited excellent
biological activities.ACKNOWLEDGEMENT
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